close

Enter

Log in using OpenID

US Infectious Disease Testing Market Size, Share, Trends, Growth, Analysis and Outlook 2016-2020

embed
Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide.
Hexa Reports
Market Research Reports and Insightful Company Profiles
US Infectious Disease Testing Market Size, Share, Trends,
Growth, Analysis and Outlook, Competitive Strategies And
Forecasts, 2015-2019
About infectious disease testing
Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites.
Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According
to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight
are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed
with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and
treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing,
POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases
increasingly threaten public health and contribute significantly to the rising costs of health care.
Browse Detail Report With TOC @ http://www.hexareports.com/report/infectious-disease-testingmarket-in-the-us-2015-2019/details
Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For
example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15
minutes.
Technavio's analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81%
over the period 2014-2019.
Covered in this report
Hexa Reports
Market Research Reports and Insightful Company Profiles
The report covers the current scenario and the growth prospects of the infectious disease testing
market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue
generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic
devices, and immunodiagnostics, which are used to detect infectious diseases:
The market is segmented based on technology:
Molecular diagnostic test
POCT
Immunodiagnostic test
The POCT for infectious disease is further segmented based on application:
HIV
Respiratory
HAIs
Sexual health
Tropical diseases
Hepatitis
In addition, the market is segmented based on products:
Equipment
Consumables
Technavio's report, Infectious Disease Testing Market in the US 2015-2019, has been prepared based on
an in-depth market analysis with inputs from industry experts. The report presents the vendor
landscape and a corresponding detailed analysis of the five key vendors in the market. The vendor
landscape focuses on vendors that provide access to new technologies. The report also outlines the
challenges faced by vendors and the market at large, as well as the key trends emerging in the market.
Key vendors
Abbott Diagnostics
Alere
Beckman Coulter Diagnostics
Roche
Siemens Healthcare
Market driver
North America free trade agreement
For a full, detailed list, view our report
Market challenge
Medical device excise tax law
For a full, detailed list, view our report
Hexa Reports
Market Research Reports and Insightful Company Profiles
Market trend
Development of innovative diagnostics initiatives
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Request A Sample copy of This Report @ http://www.hexareports.com/sample/83606
Table of Contents
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
PART 06: Infectious disease landscape in the US
Reimbursement in US
Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration
Five forces analysis
PART 07: Market segmentation by technology
Molecular diagnostic test
POCT for infectious diseases
Immunodiagnostic tests
PART 08: Market segmentation by application
PART 09: Market segmentation by product
Equipment
Consumables
Hexa Reports
Market Research Reports and Insightful Company Profiles
PART 10: Market drivers
Browse Full Report @ http://www.hexareports.com/report/infectious-disease-testing-market-in-the-us2015-2019/details
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: [email protected]
Our Website: http://www.hexareports.com/
Visit Our Blogs: http://hexareports.blogspot.in
1/--pages
Report inappropriate content